WallStreetZenWallStreetZen

NASDAQ: TLSI
Trisalus Life Sciences Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

TLSI past revenue growth

How has TLSI's revenue growth performed historically?
Company
49.31%
Industry
9.47%
Market
17.2%
TLSI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TLSI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TLSI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TLSI earnings and revenue history

Current Revenue
$18.5M
Current Earnings
-$59.0M
Current Profit Margin
-318.9%

TLSI Return on Equity

Insufficient data to display

Be the first to know when TLSI announces earnings.

TLSI Return on Assets

Current Company
-246.2%
Current Industry
5.3%
TLSI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TLSI Return on Capital Employed

Current Company
-534.63%
Current Industry
8.3%

TLSI vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TLSI$18.51M-$58.31M-$59.04M+48.44%N/A
SGHT$81.06M-$48.41M-$55.55M+60.84%N/A
LUNG$68.68M-$52.81M-$60.84M+27.98%N/A
AXGN$159.01M-$13.33M-$21.72M+13.63%N/A
TLIS$2.13M-$56.93M-$62.01M-2.24%N/A
View Top Medical Device Stocks

Trisalus Life Sciences Earnings & Revenue FAQ

What were TLSI's earnings last quarter?

Trisalus Life Sciences (NASDAQ: TLSI) reported Q4 2023 earnings per share (EPS) of -$1.05, up 98.68% year over year. Total Trisalus Life Sciences earnings for the quarter were -$35.51 million. In the same quarter last year, Trisalus Life Sciences's earnings per share (EPS) was -$79.38.

If you're new to stock investing, here's how to buy Trisalus Life Sciences stock.

What was TLSI's earnings growth in the past year?

As of Q2 2024, Trisalus Life Sciences's earnings has grown year over year. Trisalus Life Sciences's earnings in the past year totalled -$59.04 million.

What was TLSI's revenue last quarter?

Trisalus Life Sciences (NASDAQ: TLSI) reported Q4 2023 revenue of $5.72 million up 77.34% year over year. In the same quarter last year, Trisalus Life Sciences's revenue was $3.23 million.

What was TLSI's revenue growth in the past year?

As of Q2 2024, Trisalus Life Sciences's revenue has grown 49.31% year over year. This is 39.84 percentage points higher than the US Medical Devices industry revenue growth rate of 9.47%. Trisalus Life Sciences's revenue in the past year totalled $18.51 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.